Regeneus: First patient treated in Progenza stem cell trial – Proactive Investors Australia
Proactive Investors Australia |
Regeneus: First patient treated in Progenza stem cell trial
Proactive Investors Australia It also provides the potential to fast track Progenza to market given that Japan's Pharmaceuticals, Medical Devices and Other Therapeutic Products Act provides a framework for expedited approval for cell therapy products by allowing marketing following … |
